BNB Plus Corp., the OTCQB-listed company formerly known as Applied DNA Sciences (ticker BNBX), said on 2 October 2026 that it will turn itself from a digital asset treasury company focused on the BNB Chain ecosystem into an operating company that builds infrastructure for financial institutions and enterprises. The Business Wire release names blockchain and agentic AI as the technologies it wants to help institutions deploy, and it says BNB Plus is evaluating a bigger role for GlobalStake Infrastructure LLC, which has been leading its strategic review.

What BNB Plus announced on 2 October

BNB Plus says it will move away from what it calls a passive, treasury-oriented model and put its resources into a network deployment layer for open network technologies. The release says that layer is meant to give institutions the security assurances, resilience guarantees, risk management, regulatory compliance and operational accountability they need before adopting these technologies in markets that rely on traditional financial rails. BNB Plus expects to stay active in the BNB Chain ecosystem and others.

The company also said it will evaluate options for its LineaRx subsidiary, which makes enzymatic DNA used in mRNA and other genetic medicines, with the aim of realizing value for BNB Plus stockholders. The pivot therefore has two halves: a bet on financial infrastructure and a possible exit from the biotech business it carried over from its Applied DNA Sciences days.

How BNB Plus got here

The release does not explain the path to the pivot, but BNB Plus’s earlier releases do. On 13 July 2026, BNB Plus said it had received a delisting determination from the Nasdaq Hearing Panel over the minimum $1.00 bid price requirement, and that it would move to the OTCQB market and seek review from the Nasdaq Listing and Hearing Review Council. On 30 July 2026, it said it had ended its advisory and asset management arrangement with Cypress Management, LLC and would run its BNB treasury strategy in house. On 3 September 2026, it appointed three new directors identified through the strategic review, with Richard Shorten becoming Chairman.

In sequence, the announcements show a company that lost its Nasdaq listing, moved treasury management in house and reconstituted its board before changing its stated business. The 2 October release is where the strategic review produced a direction.

What the BNB Plus release does not contain

The release contains no financial figures at all. It does not say how large the BNB treasury is, how much cash BNB Plus holds, what the pivot will cost, or when any product will exist. It names no customers and no revenue target, and it gives no timetable for the LineaRx decision.

The pivot also rests on the claim that value will shift from holding digital assets to building the infrastructure around them. That is a plausible thesis, and the release offers no evidence for it beyond the company’s belief. Forward-looking language fills most of the release’s legal section, and the risk factors it lists include the company’s ability to execute an operating strategy.

Fintechbits analysis

Why the BNB Plus pivot needs a governance question answered first

The BNB Plus pivot is a strategy change announced by a company with no disclosed product, and the more pressing issue is who benefits from it. The release quotes Richard Shorten as both BNB Plus’s Chairman and the founder of GlobalStake, and it says the company is evaluating an expanded relationship with GlobalStake, which led the strategic review. Those are the same person and the same firm on both sides of a decision. That does not mean the arrangement is improper. It does mean that an independent view of the terms matters, and the release gives none.

GlobalStake describes itself in the release as a SOC 2 Type II certified Web3 infrastructure company providing validator operations, yield generation and strategic advisory services to protocol foundations, institutional investors, custodians and exchanges. That is a real business, and the logic of a treasury company handing infrastructure work to an operator is easy to follow. Fintechbits has covered how institutions are building crypto rails in earnest, from Velocity’s $38 million Series A for stablecoin corporate treasury to Block’s national trust charter application. Those stories involve regulated entities with products. BNB Plus is promising to join that field from a standing start, on the OTCQB, with a board that was refreshed in September 2026.

My read is that BNB Plus is a restructuring story told in infrastructure language. The strategic review has a destination, but the destination is a plan to assemble capabilities, and the company has not shown that institutions want to buy them from it. Treat the pivot as unproven until a customer or a contract appears.

What to Watch Next for BNB Plus

The specific thing to watch is the terms of any expanded BNB Plus agreement with GlobalStake, including who approves it and what BNB Plus pays or receives. A related-party arrangement of that kind would normally show up in a company filing or a further announcement, and its terms will say more about the pivot than the strategy language does. The second marker is the outcome of the LineaRx review, because a sale or spin-off would show how much cash the infrastructure plan can draw on.